Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.48 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.47 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.47 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9921695 | 1.00 | TDP1 (0.59) | TDP1CA12CA1CA2CA7 | |
| SCHEMBL14722551 | 1.00 | TDP1 (0.59) | TDP1CA12CA1CA2CA7 | |
| SCHEMBL14723296 | 0.92 | CES2 (0.57) | TDP1CA12CA1CA2CA7 | |
| SCHEMBL18069589 | 0.92 | TDP1 (0.55) | TDP1CA12CA1CA2CA7 | |
| SCHEMBL4576789 | 0.92 | TDP1 (0.55) | TDP1CA12CA1CA2CA7 | |
| SCHEMBL14722772 | 0.90 | TDP1 (0.53) | TDP1CA12CA1CA2CA7 | |
| SCHEMBL13225900 | 0.87 | TDP1 (0.59) | TDP1CA12CA1CA2CA7 | |
| SCHEMBL6057198 | 0.87 | CA12 (0.70) | TDP1CA12CA1CA2CA7 | |
| SCHEMBL24279406 | 0.85 | TP53 (0.55) | TDP1CA12CA1CA2CA7 | |
| SCHEMBL19170235 | 0.85 | TP53 (0.55) | TDP1CA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180162833-A1 | PROCESS FOR THE PREPARATION OF EFINACONAZOLE | GLENMARK LIFE SCIENCES LIMITED (IN) | 2018-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180162833-A1 | PROCESS FOR THE PREPARATION OF EFINACONAZOLE | CYP3A43, CYP3A5, CYP51A1 | TDP1 3790/4885CA12 4545/4885CA1 4763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.